×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [36]
上海药物研究所 [32]
中国医学科学院 北... [21]
山东大学 [15]
大连化学物理研究所 [14]
武汉大学 [10]
更多...
内容类型
期刊论文 [164]
会议论文 [15]
学位论文 [3]
专利 [1]
发表日期
2022 [2]
2021 [2]
2020 [3]
2019 [20]
2018 [16]
2017 [23]
更多...
学科主题
Oncology [3]
Pharmacolo... [3]
Chemistry [2]
物理化学 [2]
Engineerin... [1]
general & ... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共183条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Pulmonary Large Cell Neuroendocrine Carcinoma
期刊论文
PATHOLOGY & ONCOLOGY RESEARCH, 2022, 卷号: 28
作者:
Yang, Lan
;
Fan, Ying
;
Lu, Hongyang
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/23
treatment
diagnosis
LCNEC
imaging examination
pathologic features
prognosis
Efficacy and safety of radiotherapy combined with raltitrexed and irinotecan for treating unresectable recurrent colorectal cancer: a single-arm phase II trial
期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022
作者:
Li, Xinghui
;
Shen, Jinwen
;
Xia, Fan
;
Zhu, Ji
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2022/12/23
Colorectal cancer
local recurrence
intensity-modulated radiotherapy
irinotecan
raltitrexed
SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy
期刊论文
JOURNAL OF CONTROLLED RELEASE, 2021, 卷号: 339, 页码: 297-306
作者:
Huang, Ying
;
Wang, Lei
;
Cheng, Zhiyang
;
Yang, Biyu
;
Yu, Jiahui
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2021/12/01
Antitumour
Chemotherapy
SN38
Drug delivery systems
Albumin
A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor
期刊论文
JOURNAL OF SEPARATION SCIENCE, 2021, 页码: 8
作者:
Zhou, Jun
;
Zhan, Yan
;
Zhong, Dafang
;
Chen, Xiaoyan
;
Zhang, Yifan
收藏
  |  
浏览/下载:70/0
  |  
提交时间:2021/11/04
chimmitecan
mass spectrometry
pharmacokinetics
simmitecan
solid tumors
Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 8
作者:
He, Zhi-di
;
Zhang, Meng
;
Wang, Yong-hui
;
He, Yang
;
Wang, Hai-rui
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2021/05/24
tumor-targeted delivery
immunogenic cell death
PD-1
PD-L1 blockade
tumor immune microenvironment
irinotecan
JQ1
immune checkpoint
The role of critical micellization concentration in efficacy and toxicity of supramolecular polymers
期刊论文
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 卷号: 117, 期号: 9, 页码: 4518-4526
作者:
Su, Hao
;
Wang, Feihu
;
Ran, Wei
;
Zhang, Weijie
;
Dai, Wenbing
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2020/07/01
critical micellization concentration
molecular assembly
supramolecular polymers
drug delivery
prodrugs
Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy
期刊论文
THERANOSTICS, 2020, 卷号: 10, 期号: 8, 页码: 3722-3736
作者:
Li, Ying
;
Miao, Yunqiu
;
Chen, Mingshu
;
Chen, Xi
;
Li, Feifei
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2020/07/01
drug delivery
pH sensitive
charge conversion
tumor targeting
hepatocellular carcinoma
Discovery of dihydrooxazolo[2,3-a]isoquinoliniums as highly specific inhibitors of hCE2
期刊论文
RSC ADVANCES, 2019, 卷号: 9, 期号: 61, 页码: 35904-35912
作者:
Ding, Lixia
;
Wang, Lu
;
Zou, Kun
;
Li, Bo
;
Song, Yunqing
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/07/01
An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1*1*1 genotype
期刊论文
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 卷号: 12
作者:
Guan, Yun
;
Shen, Yunzhu
;
Xu, Ye
;
Li, Chao
;
Wang, Jingwen
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2019/12/05
intensity-modulated radiation therapy
irinotecan
neoadjuvant chemoradiotherapy
rectal cancer
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:112/0
  |  
提交时间:2019/12/05
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
©版权所有 ©2017 CSpace - Powered by
CSpace